XML 53 R43.htm IDEA: XBRL DOCUMENT v3.25.2
NOTES PAYABLE AND DERIVATIVE LIABILITIES (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Apr. 17, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Mar. 31, 2025
Dec. 31, 2024
Jun. 26, 2024
Debt Instrument [Line Items]              
Shares issued     51,203        
Original issue discount $ 43,750            
Derivative liability     $ 2,133,599        
Derivative liability     3,859,748   $ 1,382,750    
Issuance of shares   39,880          
Issuance of shares, value   $ 58,624        
Notes payable 168,750            
Cash proceeds $ 125,000   395,474 $ 200      
Protagenic Therapeutics Inc [Member]              
Debt Instrument [Line Items]              
Notes payable     1,117,778        
Transaction costs     18,260        
Derivative liability         343,399    
Phytanix Bio [Member]              
Debt Instrument [Line Items]              
Derivative liability     2,133,599   $ 1,324,126    
Securities Purchase Agreements [Member]              
Debt Instrument [Line Items]              
Original principal amount           $ 3,193,650 $ 4,413,650
Long term debt             $ 3,193,650
Share price           $ 11.00  
Original issue discount     $ 199,603     $ 798,412  
Securities Purchase Agreements [Member] | Series A Preferred Warrants [Member]              
Debt Instrument [Line Items]              
Share price           $ 159.86  
Shares issued           1,127  
Securities Purchase Agreements [Member] | Series B Preferred Warrants [Member]              
Debt Instrument [Line Items]              
Share price           $ 61.91  
Shares issued           2,436  
Securities Purchase Agreements [Member] | Common Warrant [Member]              
Debt Instrument [Line Items]              
Share price           $ 1.47  
Original principal amount           $ 993,151  
Securities Purchase Agreements [Member] | Maximum [Member]              
Debt Instrument [Line Items]              
Warrants to purchase           675,613